Literature DB >> 1268141

Studies in the involvement of prostaglandins in uterine symptomatology and pathology.

E A Willman, W P Collins, S G Clayton.   

Abstract

The concentrations of prostaglandin E2 and F2alpha were measured by radioimmunoassay in samples of endometrial tissue from 155 women. The results showed that the concentration of prostaglandins E2 (ng/100 mg of wet tissue; mean +/- SD) in tissue from apparently healthy women with regular menstrual cycles was 79-3 +/- 9-9 during the menstrual period. The level in the proliferative and early secretory phases fell to 11-8 +/- 4-0 and 13-3 +/- 8-3 respectively. During the late secretory phase there was a significant increase to 20-1 +/- 10-8. The corresponding values from patients with fibromyomata and without menorrhagia were similar. However, the concentration in tissue from patients with fibromyomata and menorrhagia was significantly higher (63-9 +/- 17-9) during the secretory phase of the uterine cycle. In addition, the amount was significantly higher in the groups with dysmenorrhoea (19-0 +/- 4-5 proliferative; 68-0 +/-18-15 secretory) and irregular uterine bleeding (78-3 +/- 59-0 proliferative; 87-4 +/- 64-9 secretory). The mean concentration was higher in cases of endometriosis, and significantly elevated in endometrial carcinoma. The results for prostaglandin F2alpha showed a similar pattern, but the changes were less marked in patients with irregular dysfunctional bleeding. The findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1268141     DOI: 10.1111/j.1471-0528.1976.tb00839.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  18 in total

1.  Stress and dysmenorrhoea: a population based prospective study.

Authors:  L Wang; X Wang; W Wang; C Chen; A G Ronnennberg; W Guang; A Huang; Z Fang; T Zang; L Wang; X Xu
Journal:  Occup Environ Med       Date:  2004-12       Impact factor: 4.402

2.  Menstrual cycle changes in women with inflammatory bowel disease: a study from the ocean state Crohn's and colitis area registry.

Authors:  Sumona Saha; Ying-Qi Zhao; Samir A Shah; Silvia Degli Esposti; Sheldon Lidofsky; Sana Salih; Renee Bright; Meaghan Law; Heather Moniz; Nicole Flowers; Marjorie Merrick; Bruce E Sands
Journal:  Inflamm Bowel Dis       Date:  2014-03       Impact factor: 5.325

3.  Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding.

Authors:  Magdalena Bofill Rodriguez; Anne Lethaby; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2019-09-19

4.  The pathology of endometriosis.

Authors:  H Fox
Journal:  Ir J Med Sci       Date:  1983-06       Impact factor: 1.568

5.  The treatment of unexplained menorrhagia.

Authors:  E Cope
Journal:  Ir J Med Sci       Date:  1983-06       Impact factor: 1.568

6.  Danazol in the treatment of menorrhagia.

Authors:  E Cope
Journal:  Drugs       Date:  1980-05       Impact factor: 9.546

7.  Dysfunctional uterine bleeding.

Authors:  V H Livingstone
Journal:  Can Fam Physician       Date:  1987-11       Impact factor: 3.275

8.  Dysmenorrhea in women with Crohn's disease: a case-control study.

Authors:  Sumona Saha; Emilie Midtling; Erica Roberson; Veena A Nair; Arnold Wald; Mark Reichelderfer
Journal:  Inflamm Bowel Dis       Date:  2013-06       Impact factor: 5.325

Review 9.  Dysmenorrhoea and prostaglandins: pharmacological and therapeutic considerations.

Authors:  M Y Dawood
Journal:  Drugs       Date:  1981-07       Impact factor: 9.546

10.  Efficacy of ketoprofen in treating primary dysmenorrhea.

Authors:  S Gleeson; J Sorbie
Journal:  Can Med Assoc J       Date:  1983-10-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.